PCV11- THE COST-EFFECTIVENESS OF LEVOSIMENDAN IN SEVERE LOW-OUTPUT HEART FAILURE COMPARED TO DOBUTAMINE BASED ON AN INTERNATIONAL CLINICAL TRIAL (LIDO)
Sep 1, 2001, 00:00
10.1016/S1098-3015(11)71713-2
https://www.valueinhealthjournal.com/article/S1098-3015(11)71713-2/fulltext
Title :
PCV11- THE COST-EFFECTIVENESS OF LEVOSIMENDAN IN SEVERE LOW-OUTPUT HEART FAILURE COMPARED TO DOBUTAMINE BASED ON AN INTERNATIONAL CLINICAL TRIAL (LIDO)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71713-2&doi=10.1016/S1098-3015(11)71713-2
First page :
Section Title :
Open access? :
No
Section Order :
228